Functional interaction of bone morphogenetic protein and growth hormone releasing peptide in adrenocorticotropin regulation by corticotrope cells
Authors:
- 1 July 2011
- journal article
- Published by Elsevier in Molecular and Cellular Endocrinology
- Vol. 344 (1-2) , 41-50
Abstract
No abstract availableKeywords
This publication has 42 references indexed in Scilit:
- Estrogen and glucocorticoid regulate osteoblast differentiation through the interaction of bone morphogenetic protein-2 and tumor necrosis factor-α in C2C12 cellsMolecular and Cellular Endocrinology, 2010
- Structure–activity relationship study of bone morphogenetic protein (BMP) signaling inhibitorsBioorganic & Medicinal Chemistry Letters, 2008
- Dorsomorphin inhibits BMP signals required for embryogenesis and iron metabolismNature Chemical Biology, 2007
- CRF signaling: molecular specificity for drug targeting in the CNSTrends in Pharmacological Sciences, 2006
- Molecular Basis of Bone Morphogenetic Protein-15 Signaling in Granulosa CellsJournal of Biological Chemistry, 2003
- Pituitary Development: Regulatory Codes in Mammalian OrganogenesisScience, 2002
- The Growth Hormone Secretagogue Hexarelin Stimulates the Hypothalamo-Pituitary-Adrenal Axis via Arginine VasopressinThe Journal of Clinical Endocrinology & Metabolism, 1999
- Regulation of the Rat Proopiomelanocortin Gene Expression in AtT-20 Cells. I: Effects of the Common SecretagoguesEndocrinology, 1997
- Activation of the Hypothalamo-Pituitary-Adrenal Axis by the Growth Hormone (GH) Secretagogue, GH-Releasing Peptide-6, in RatsEndocrinology, 1997
- GH Releasing Peptides - Structure and KineticsJournal of Pediatric Endocrinology and Metabolism, 1993